Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(40%)

Phase Distribution

Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(1)
Terminated(2)
Other(1)

Detailed Status

Terminated2
unknown1
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
33.3%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown120%
completed120%
not_yet_recruiting120%
terminated240%

Recent Activity

0 active trials
Showing 5 of 5
terminated

Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization

NCT03788369
not_yet_recruitingnot_applicable

Hybrid Revascularization Versus Coronary Artery Bypass Grafting

NCT05504031
terminatednot_applicable

FUNctional eFficacy of Hybrid coronAry REvascularization

NCT04698460
unknownnot_applicable

Optimizing Strategy of Coronary Revascularization in Patients With Multivessel Lesions Combined Heart Failure

NCT02775578
completed

Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy

NCT02293928

Clinical Trials (5)

Showing 5 of 5 trials
NCT03788369

Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization

Terminated
NCT05504031Not Applicable

Hybrid Revascularization Versus Coronary Artery Bypass Grafting

Not Yet Recruiting
NCT04698460Not Applicable

FUNctional eFficacy of Hybrid coronAry REvascularization

Terminated
NCT02775578Not Applicable

Optimizing Strategy of Coronary Revascularization in Patients With Multivessel Lesions Combined Heart Failure

Unknown
NCT02293928

Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5